These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 32837912)

  • 1. JTH editorial v17 - The importance of psychosocial factors in transport and health.
    Musselwhite CBA
    J Transp Health; 2020 May; ():100876. PubMed ID: 32837912
    [No Abstract]   [Full Text] [Related]  

  • 2. Partial suppression of an Escherichia coli TonB transmembrane domain mutation (delta V17) by a missense mutation in ExbB.
    Larsen RA; Thomas MG; Wood GE; Postle K
    Mol Microbiol; 1994 Aug; 13(4):627-40. PubMed ID: 7997175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Editorial JTH 16 -The Coronavirus Disease COVID-19 and implications for transport and health.
    Musselwhite C; Avineri E; Susilo Y
    J Transp Health; 2020 Mar; 16():100853. PubMed ID: 32337154
    [No Abstract]   [Full Text] [Related]  

  • 4. Distribution of alpha1L-adrenoceptors in canine prostate: characterization by quantitative autoradiography.
    Suzuki Y; Moriyama N; Okaya Y; Kanada A; Nishimatsu H; Kawabe K; Aisaka K
    J Pharm Pharmacol; 2000 Jun; 52(6):653-7. PubMed ID: 10875541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New alpha1-adrenoceptor antagonist, JTH-601, shows more than 10 times higher affinity for human prostates than arteries.
    Takahashi M; Taniguchi T; Murata S; Okada K; Moriyama N; Yamazaki S; Muramatsu I
    J Urol; 1999 Apr; 161(4):1350-4. PubMed ID: 10081906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological characteristics of inhibitory action of the selective alpha1-antagonist JTH-601 on the positive inotropic effect mediated by alpha1-adrenoceptors in isolated rabbit papillary muscle.
    Qiao X; Norota I; Endoh M
    Jpn J Pharmacol; 2000 Nov; 84(3):301-9. PubMed ID: 11138731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disposition and alpha(1)-adrenoceptor binding characteristics of JTH-601 and its metabolites in rat tissues.
    Yamada S; Okura T; Kimura R; Deguchi Y; Suzuki Y; Kobayashi T; Aisaka K
    Drug Metab Dispos; 2000 Dec; 28(12):1487-92. PubMed ID: 11095588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of JTH-601, a novel alpha(1)-adrenoceptor antagonist, on prostate function in dogs.
    Suzuki Y; Kanada A; Okaya Y; Aisaka K
    Eur J Pharmacol; 2000 Apr; 394(1):123-30. PubMed ID: 10771044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostate selectivity of JTH-601-G1, an active metabolite of JTH-601, in dogs.
    Suzuki Y; Kanada A; Okaya Y; Kurahashi Y; Kogayu M; Kobayashi T; Aisaka K
    BJU Int; 2000 Mar; 85(4):542-50. PubMed ID: 10691841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ex vivo and in vivo alpha1-adrenoceptor binding characteristics of a novel alpha1L-adrenoceptor antagonist, JTH-601, in rat tissues.
    Ohkura T; Yamada S; Tohma A; Kimura R; Aisaka K
    Biol Pharm Bull; 1999 Jul; 22(7):687-90. PubMed ID: 10443463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of JTH-601, a novel alpha1-adrenoceptor antagonist, on the function of lower urinary tract and blood pressure.
    Suzuki Y; Kanada A; Okaya Y; Aisaka K; Muramatsu I
    Eur J Pharmacol; 1999 Jun; 374(3):495-502. PubMed ID: 10422795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [CMTM1-v17, a new potential corepressor of androgen receptor].
    Zhu BM; Li T; Zhou YL; Song QS; Wang L
    Beijing Da Xue Xue Bao Yi Xue Ban; 2007 Aug; 39(4):388-93. PubMed ID: 17657266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CMTM1_v17 is associated with chemotherapy resistance and poor prognosis in non-small cell lung cancer.
    Si J; Zhang P; Tian D; Wang X; Ma Y; Zhang J; Wang L; Yang Y
    World J Surg Oncol; 2017 Jan; 15(1):34. PubMed ID: 28129775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CMTM1_v17 is a novel potential therapeutic target in breast cancer.
    Wang J; Zhang G; Zhang Y; Luo Y; Song Q; Qiu X; Mo X; Wang L
    Oncol Rep; 2014 Nov; 32(5):1829-36. PubMed ID: 25175386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological characterization of [3H]-JTH-601, a novel alpha1-adrenoceptor antagonist: binding to recombinant human alpha1-adrenoceptors and human prostates.
    Takahashi M; Taniguchi T; Kanamaru H; Okada K; Muramatsu I
    Life Sci; 2000 Oct; 67(20):2443-51. PubMed ID: 11065167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sch-28080 inhibits bafilomycin-sensitive H+ secretion in turtle bladder independently of luminal [K+].
    Kohn OF; Mitchell PP; Steinmetz PR
    Am J Physiol; 1993 Aug; 265(2 Pt 2):F174-9. PubMed ID: 8368331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The state of JTH.
    Rosendaal FR; Reitsma PH
    J Thromb Haemost; 2016 Mar; 14(3):419. PubMed ID: 26892247
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of JTH-601, a putative alpha(1L)-adrenoceptor antagonist, on guinea pig nasal mucosa vasculature.
    Hirai T; Tsuru H; Tanimitsu N; Yajin K; Sasa M
    Eur J Pharmacol; 2001 Mar; 416(1-2):141-4. PubMed ID: 11282123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rasch analysis of the Antimicrobial Self-Assessment Toolkit for National Health Service (NHS) Trusts (ASAT v17).
    Bailey C; Tully MP; Pampaka M; Cooke J
    J Antimicrob Chemother; 2017 Feb; 72(2):604-613. PubMed ID: 27798214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo receptor binding of novel alpha1-adrenoceptor antagonists for treatment of benign prostatic hyperplasia.
    Yamada S; Ohkura T; Kimura R; Kawabe K
    Life Sci; 1998; 62(17-18):1585-9. PubMed ID: 9585140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.